Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.400NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.2.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.16 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.46.1 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.37 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.336NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.317NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.54NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.5.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
BQ.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DG.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.56NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDP.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HN.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.24.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.2.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FL.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.13NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GA.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.58NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GH.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.96NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EZ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used